Tag: Medtronic
Medtronic’s InPen app gets FDA clearance
November 21, 2024HME News Staff
GALWAY, Ireland - Medtronic has received clearance from the U.S. Food and Drug Administration for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor. With this clearance, the system will be the first in the market to recommend corrections for missed or inaccurate insulin doses, providing real-time, personalized insights for individuals on multiple daily injection therapy, the company says. ...
In brief: Abbott, Medtronic partner & InfuSystem, Smith+Nephew partner
August 9, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott will enter a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology and Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
The integration of Abbott's CGM sensor with Medtronic's AID algorithms will enable automatic adjustments of insulin to keep glucose in range, the companies say.
"This partnership pairs...
Medtronic CGM gets nod from FDA
August 7, 2024HME News Staff
MINNEAPOLIS – Medtronic’s Simplera continuous glucose monitor (CGM) has received regulatory approval from the U.S. Food and Drug Administration. Simplera, the company's first disposable, all-in-one continuous glucose monitor, is half the size of its previous CGMs. The Medtronic Simplera platform includes the Simplera CGM, which is designed to be used as part of a Smart MDI system with the InPen smart insulin pen; and the Simplera Sync sensor, which is designed to be integrated with...
Abbott, Medtronic partner on diabetes system
August 7, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott will enter a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology and Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
The integration of Abbott's CGM sensor with Medtronic's AID algorithms will enable automatic adjustments of insulin to keep glucose in range, the companies say.
"This partnership pairs...
In brief: AAHomecare survey, Bigfoot sale, Medtronic lawsuit
September 8, 2023HME News Staff
WASHINGTON – AAHomecare has launched a survey to learn what education topics would be most beneficial to an HME company’s livelihood and operations.
The association will use the results of the survey to help shape a curriculum featuring respected thought leaders from the HME Industry and beyond that addresses pressing concerns.
“In a recent industry survey, nearly 250 HME professionals nationwide shared business pain points revealing critical challenges impacting...
Lawsuit accuses Medtronic of sharing patient data
September 6, 2023HME News Staff
DUBLIN – A lawsuit filed against Medtronic alleges that the company’s insulin delivery devices shared patient data with third parties, including Google, in violation of HIPAA and other industry standards, according to online news reports.
The lawsuit, filed by “A.H.” in U.S. District Court in Central California, alleges that Medtronic and its MiniMed and InPen devices transmit personally identifiable information and protected health information to third parties.
Per...
Medtronic launches more effective infusion set
November 22, 2022HME News Staff
DUBLIN – Medtronic has announced the U.S. launch of its Extended infusion set, which it says is the first and only infusion set labelled for up to seven-day wear. An infusion set is tubing that delivers insulin from a pump to the body and typically requires a set change every two to three days. "When patients first begin using a pump, doctors and other health care providers reinforce the need to change their infusion set every two to three days to limit the risk of infection and other safety...
Medtronic, OneDrop earn CE Marks
May 27, 2021HME News Staff
Medtronic, a global medical technology company based in Dublin, Ireland, has received CE (Conformité Européenne) Marks for the expanded functionality of its InPen smart insulin pen for multiple daily injections and for its Guardian 4 sensor, which requires no fingersticks for calibration or diabetes treatment decisions. The CE Marks allow this next-generation sensor to be integrated with either the MiniMed 780G insulin pump system or InPen,...
Short takes: Medtronic, NCART
April 15, 2021HME News Staff
Medtronic has launched the Medtronic Extended infusion set, the first insulin infusion set that can be worn for up to seven days, up from the recommended three days. The set is compatible with all MiniMed 600 and 700 series insulin pumps. The set is now commercially available in select European countries, starting with Finland and Belgium…NCART and Access2CRT have revamped their websites. The NCART website remains a CRT industry resource center with the latest news and tools...
Medtronic aims to ‘bridge’ coverage gaps
December 18, 2020Theresa Flaherty, Managing Editor
DUBLIN – The biggest barrier to CGMs and other innovative diabetes technology is cost, says Medtronic, and that’s why the company recently launched a CGM Access Discount Program for certain users.
“Our goal is to make therapy available to everyone and we hear cost is one of the top reasons they can’t go on CGMs or fall off (using CGMs),” says Krista Sugerman, vice president of global customer engagement for Medtronic. “We try to...